mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.6 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.6 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.6 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.6 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |